Aponvie 32 mg/4.4 mL (7.2 mg/mL) injection Images
Generic Name: aprepitant
This medication has been identified as Aponvie 32 mg/4.4 mL (7.2 mg/mL) injection. It is supplied by Heron Therapeutics, Inc.
Aponvie is used in the treatment of Nausea/Vomiting; Nausea/Vomiting, Postoperative and belongs to the drug class NK1 receptor antagonists. There is no proven risk in humans during pregnancy. Aponvie 32 mg/4.4 mL (7.2 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Aponvie
- Generic Name
- aprepitant
- Strength
- 32 mg/4.4 mL (7.2 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- NK1 receptor antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Heron Therapeutics, Inc.
- National Drug Code (NDC)
- 47426-0401
More about Aponvie (aprepitant)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: NK1 receptor antagonists
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
